Ablative Solutions has pulled in $2.4 million in a new round of financing, looking to raise another $4 million in the round, according to an SEC filing posted last week. The Kalamazoo, Mich.-based company developed and produces the Peregrine infusion ablation catheter for treating hypertension. The Peregrine system infuses neurolytic agents into the perivascular space […]
Ablative Solutions
Renal denervation: Ablative Solutions wins CE Mark for chemical ablation catheter
Ablative Solutions tests infusion ablation catheter as hypertension treatment
Hypertension: Ablative Solutions lands $8M for renal denervation tech
Ablative Solutions, which is developing perivascular renal denervation technology for treating high blood pressure, raised an $8.0 million funding round, according to a regulatory filing.
Menlo Park, Calif.-based Ablative Solutions said 98 unnamed investors participated in the funding round, which consisted of debt, options and warrants.
Hypertension: Ablative Solutions reels in $2.7M for renal denervation device
Ablative Solutions added to its coffers yesterday, reporting a $2.7 million raise out of a hoped-for $5 million as it works to develop its perivascular renal denervation technology for treating high blood pressure.
Menlo Park, Calif.-based Ablative said 41 unnamed investors joined the debt, options and warrants round.
Medtech funding: Ablative Solutions raises $1.1 million
Ablative Solutions reported raising $1.1 million in an April 4, 2013, regulatory filing:
Company: Ablative Solutions
Raise: $1.1 million
Security: Debt, Options/Warrants
Investors: 13
Sales Commission: $0
Finders’ Fees: $0